Literature DB >> 28593818

Sensitivity and specificity should never be interpreted in isolation without consideration of other clinical utility metrics.

Rael T Lange1,2,3,4, Sara M Lippa1,2,3.   

Abstract

OBJECTIVE: The purpose of this paper is to highlight the risks and pitfalls of interpreting sensitivity and specificity in isolation when evaluating the clinical utility of a new test/measure to predict a target behavior, disease, or condition.
METHOD: This paper (a) provides a primer for a set of metrics that can be used to appropriately examine the clinical utility of a test/measure (i.e. test operating characteristics - TOC), and (b) provides a discussion regarding various interpretative considerations when using TOCs that supports the tenet of this paper.
CONCLUSIONS: There are two primary conclusions. First, sensitivity and specificity should never be interpreted in isolation as a means for evaluating the clinical utility of a test/measure. When sensitivity and specificity are used in this manner, more often than not, this will result in erroneous and/or incomplete conclusions regarding the clinical utility of a new test/measure. Second, sensitivity and specificity values are important, but they must be interpreted in conjunction with other more relevant clinical utility metrics (e.g. positive predictive power and negative predictive power).

Entities:  

Keywords:  Test operating characteristics; predictive power; psychometrics; sensitivity; specificity

Mesh:

Year:  2017        PMID: 28593818     DOI: 10.1080/13854046.2017.1335438

Source DB:  PubMed          Journal:  Clin Neuropsychol        ISSN: 1385-4046            Impact factor:   3.535


  3 in total

1.  Dysphagia Management and Cervical Auscultation: Reliability and Validity Against FEES.

Authors:  Mariam Jaghbeer; Anna-Liisa Sutt; Liza Bergström
Journal:  Dysphagia       Date:  2022-07-15       Impact factor: 2.733

2.  A parent-reported standardised checklist is not sensitive to screen for motor problems at school age following neonatal critical illness.

Authors:  Leontien C C Toussaint-Duyster; Monique H M van der Cammen-van Zijp; Dick Tibboel; Saskia Gischler; Joost van Rosmalen; Hanneke IJsselstijn
Journal:  Acta Paediatr       Date:  2020-02-22       Impact factor: 2.299

3.  Predicting Probability of Response to Tumor Necrosis Factor Inhibitors for Individual Patients With Ankylosing Spondylitis.

Authors:  Runsheng Wang; Abhijit Dasgupta; Michael M Ward
Journal:  JAMA Netw Open       Date:  2022-03-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.